Version 5.4
Bos taurus Protein: BCKDHB
Summary
InnateDB Protein IDBP-681573.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BCKDHB
Protein Name 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial precursor
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000055109
InnateDB Gene IDBG-630116 (BCKDHB)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003824 catalytic activity
GO:0003826 alpha-ketoacid dehydrogenase activity
GO:0005515 protein binding
Biological Process
GO:0008152 metabolic process
GO:0009083 branched-chain amino acid catabolic process
Cellular Component
GO:0005739 mitochondrion
GO:0005947 mitochondrial alpha-ketoglutarate dehydrogenase complex
Protein Structure and Domains
PDB ID
InterPro IPR005476 Transketolase, C-terminal
IPR009014 Transketolase, C-terminal/Pyruvate-ferredoxin oxidoreductase, domain II
IPR029061 Thiamin diphosphate-binding fold
PFAM PF02780
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL G3MZV5
UniProt Splice Variant
Entrez Gene 282150
UniGene Bt.5412
RefSeq
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02025432 DAAA02025433 DAAA02025434 DAAA02025435 DAAA02025436 DAAA02025437 DAAA02025438
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca